HP and gastric cancer: Compared to no evidence from the target population, the more frequent observation of improvements in precancerous gastric pathology observed in participants whose Hp density reduced during follow-up relative to those whose Hp density did not constitutes compelling evidence that treatment to eliminate Hp infection has the potential to reduce stomach cancer risk in participating communities.